The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers

Advances in Immunology

Volumn 106, Issue C, 2010, Pages 93-133

  Zhang, Yu ^a,b,c,d   Gostissa, Monica ^a,b,c,d   Hildebrand, Dominic G ^a,b,c,d   Becker, Michael S ^a,b,c,d   Boboila, Cristian ^a,b,c,d   Chiarle, Roberto ^a,b,c,d   Lewis, Susanna ^a,b,c,d   Alt, Frederick W ^a,b,c,d  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b CENTER FOR BLOOD RESEARCH   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMATINIB; IMMUNOGLOBULIN; IMMUNOGLOBULIN H; PROTEIN BCL 2; RECOMBINASE; UNCLASSIFIED DRUG;

B CELL LYMPHOMA; B LYMPHOCYTE; BOOK; CANCER GROWTH; CARCINOGENESIS; CELL MATURATION; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; DNA RECOMBINATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; EPITHELIUM TUMOR; GENE LOCUS; HEMATOLOGIC MALIGNANCY; HUMAN; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MULTIPLE MYELOMA; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; SOLID TUMOR; SOMATIC HYPERMUTATION; T LYMPHOCYTE; ANIMAL; CHROMOSOME BREAKAGE; GENE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC RECOMBINATION; GENETICS; LEUKEMIA; NEOPLASM; PHYSIOLOGY; REGULATORY SEQUENCE;

ANIMALS; B-LYMPHOCYTES; CHROMOSOME BREAKAGE; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAG-1; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; LEUKEMIA; LYMPHOMA; NEOPLASMS; PHILADELPHIA CHROMOSOME; RECOMBINATION, GENETIC; REGULATORY SEQUENCES, NUCLEIC ACID; T-LYMPHOCYTES; TRANSLOCATION, GENETIC;

EID: 77955875047     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/S0065-2776(10)06004-9     Document Type: Chapter

References (218)

1. Abraham R.T. Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001, 15:2177-2196.
2. Adams J.M., Harris A.W., Pinkert C.A., Corcoran L.M., Alexander W.S., Cory S., Palmiter R.D., Brinster R.L. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985, 318:533-538.
3. Ahnesorg P., Smith P., Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous endjoining. Cell 2006, 124:301-313.
4. Akopiant K., Zhou R.-Z., Mohapatra S., Valerie K., Lees-Miller S.P., Lee K.-J., Chen D.J., Revy P., de Villartay J.-P., Povirk L.F. Requirement for XLF/Cernunnos in alignment-based gap filling by DNA polymerases l and m for nonhomolgous end joining in human whole-cell extracts. Nucleic Acids Res. 2009, 37:4055-4062.
5. Alt F.W., Baltimore D. Joining of immunoglobulin heavy chain gene segments: Implications from a chromosome with evidence of three D-JH fusions. Proc. Natl. Acad. Sci. USA 1982, 79:4118-4122.
6. Audebert M., Salles B., Calsou P. Involvement of poly(ADP-ribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J. Biol. Chem. 2004, 279:55117-55126.
7. Bartram C.R., de Klein A., Hagemeijer A., van Agthoven T., Geurts van Kessel A., Bootsma D., Grosveld G., Ferguson-Smith M.A., Davies T., Stone M., et al. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1983, 306:277-280.
8. Bassing C.H., Suh H., Ferguson D.O., Chua K.F., Manis J., Eckersdorff M., Gleason M., Bronson R., Lee C., Alt F.W. Histone H2AX: A dosage-dependent suppressor of oncogenic translocations and tumors. Cell 2003, 114:359-370.
9. Bassing C.H., Alt F.W. H2AX may function as an anchor to hold broken chromosomal DNA ends in close proximity. Cell Cycle. 2004, 3:149-153.
10. Bernstein K.A., Rothstein R. At loose ends: Resecting a double-strand break. Cell 2009, 137:807-810.
11. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
12. Boboila C., Yan C., Wesemann D.R., Jankovic M., Wang J.H., Manis J., Nussenzweig A., Nussenzweig M., Alt F.W., Nussenzweig M.C., et al. Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4. J. Exp. Med. 2010, 207:417-427.
13. Boboila C., Jankovic M., Yan C.T., Wang J.H., Wesemann D.R., Zhang T., Fazeli A., Feldman L., Nussenzweig A., Nussenzweig M., Alt F.W. Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc. Natl. Acad. Sci. USA 2010, 107:3034-3039.
14. Boulton S.J., Jackson S.P. Saccharomyces cerevisiae Ku70 potentiates illegitimate DNA double-strand break repair and serves as a barrier to error-prone DNA repair pathways. EMBO J. 1996, 15:5093-5103.
15. Boveri T. Zur Frage der Entstehung maligner Tumoren 1914, Gustav-Fischer-Verlag, Jena, 164 [English translation by Boveri, M. (1929). Arch. Intern. Med. 44, 910].
16. Bredemeyer A.L., Sharma G.G., Huang C., Helmink B.A., Walker L.M., Khor K.C., Nuskey B., Sullivan K.E., Pandita T.K., Bassing C.H., Sleckman B.P. ATM stabilizes DNA double-strand-break complexes during V(D)J recombination. Nature 2006, 442:466-470.
17. Brenner J.C., Chinnaiyan A.M. Translocations in epithelial cancers. Biochim. Biophys. Acta 2009, 1796:201-215.
18. Bridger J.M., Boyle S., Kill I.R., Bickmore W.A. Re-modelling of nuclear architecture in quiescent and senescent human fibroblasts. Curr. Biol. 2000, 10:149-152.
19. Buck D., Malivert L., de Chasseval R., Barraud A., Fondanèche M.C., Sanal O., Plebani A., Stéphan J.L., Hufnagel M., le Deist F., Fischer A., Durandy A., et al. Cernunnos, a novel 111 nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 2006, 124:287-299.
20. Callén E., Jankovic M., Difilippantonio S., Daniel J.A., Chen H.T., Celeste A., Pellegrini M., McBride K., Wangsa D., Bredemeyer A.L., Sleckman B.P., Ried T., et al. ATM prevents the persistence and propagation of chromosome breaks in lymphocytes. Cell 2007, 130:63-75.
21. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998, 281:1677-1679.
22. Carver B.S., Tran J., Chen Z., Carracedo-Perez A., Alimonti A., Nardella C., Gopalan A., Scardino P.T., Cordon-Cardo C., Gerald W., Pandolfi P.P. ETS rearrangements and prostate cancer initiation. Nature 2009, 457:E1. discussion E2-3.
23. Carver B.S., Tran J., Gopalan A., Chen Z., Shaikh S., Carracedo A., Alimonti A., Nardella C., Varmeh S., Scardino P.T., Cordon-Cardo C., Gerald W., et al. Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate. Nat. Genet. 2009, 41:619-624.
24. Celeste A., Difilippantonio S., Difilippantonio M.J., Fernandez-Capetillo O., Pilch D.R., Sedelnikova O.A., Eckhaus M., Ried T., Bonner W.M., Nussenzweig A. H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 2003, 114:371-383.
25. Chang C., Biedermann K.A., Mezzina M., Brown J.M. Characterization of the DNA double strand break repair defect in scid mice. Cancer Res. 1993, 53:1244-1248.
26. Chaudhuri J., Basu U., Zarrin A., Yan C., Franco S., Perlot T., Vuong B., Wang J., Phan R.T., Datta A., Manis J., Alt F.W. Evolution of the immunoglobulin heavy chain class switch recombination mechanism. Adv. Immunol. 2007, 94:157-214.
27. Chen B.P., Chan D.W., Kobayashi J., et al. Cell cycle dependence of DNA-dependent protein kinase phosphorylation in response to DNA double strand breaks. J. Biol. Chem. 2005, 280:14709-14715.
28. Cheng H.L., Vuong B.Q., Basu U., Franklin A., Schwer B., Astarita J., Phan R.T., Datta A., Manis J., Alt F.W., Chaudhuri J. Integrity of the AID serine-38 phosphorylation site is critical for class switch recombination and somatic hypermutation in mice. Proc. Natl. Acad Sci. USA 2009, 106:2717-2722.
29. Clikeman J.A., Khalsa G.J., Barton S.L., Nickoloff J.A. Homologous recombinational repair of double-strand breaks in yeast is enhanced by MAT heterozygosity through yKu-dependent and -independent mechanisms. Genetics 2001, 157:579-589.
30. Cogné M., Lansford R., Bottaro A., Zhang J., Gorman J., Young F., Cheng H.L., Alt F.W. A class switch control region at the 3' end of the immunoglobulin heavy chain locus. Cell 1994, 77:737-747.
31. Corneo B., Wendland R.L., Deriano L., Cui X., Klein I.A., Wong S.Y., Arnal S., Holub A.J., Weller G.R., Pancake B.A., Shah S., Brandt V.L., et al. Rag mutations reveal robust alternative end joining. Nature 2007, 449:483-486.
32. Cremer T., Cremer C. Chromosome territories, nuclear architecture and gene regulation in mammalian cells. Nat. Rev. Genet. 2001, 2:292-301.
33. Cremer M., Küpper K., Wagler B., Wizelman L., von Hase J., Weiland Y., Kreja L., Diebold J., Speicher M.R., Cremer T. Inheritance of gene density-related higher order chromatin arrangements in normal and tumor cell nuclei. J. Cell Biol. 2003, 162:809-820.
34. Cui X., Meek K. Linking double-stranded DNA breaks to the recombination activating gene complex directs repair to the nonhomologous end-joining pathway. Proc. Natl. Acad. Sci. USA 2007, 104:17046-17051.
35. Dahm K. Functions and regulation of human artemis in double strand break repair. J. Cell. Biochem. 2007, 100:1346-1351.
36. D'Amours D., Jackson S.P. The Mre11 complex: At the crossroads of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 2002, 3:317-327.
37. DeFazio L.G., Stansel R.M., Griffith J.D., Chu G. Synapsis of DNA ends by DNA-dependent protein kinase. EMBO J. 2002, 21:3192-3200.
38. de Klein A., van Kessel A.G., Grosveld G. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 1982, 300:765-767.
39. de Lange T. How telomeres solve the end-protection problem. Science 2009, 326:948-952.
40. Deriano L., Stracker T.H., Baker A., Petrini J.H., Roth D.B. Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates. Mol. Cell 2009, 34:13-25.
41. Desiderio S., Lin W.C., Li Z. The cell cycle and V(D)J recombination. Curr. Top. Microbiol. Immunol. 1996, 217:45-59.
42. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000, 404:510-514.
43. Difilippantonio M., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 2002, 196:469-480.
44. Difilippantonio S., Gapud E., Wong N., Huang C.Y., Mahowald G., Chen H.T., Kruhlak M.J., Callen E., Livak F., Nussenzweig M.C., Sleckman B.P., Nussenzweig A. 53BP1 facilitates long-range DNA end-joining during V(D)J recombination. Nature 2008, 456:529-533.
45. Dinkelmann M., Spehalski E., Stoneham T., Buis J., Wu Y., Sekiguchi J.M., Ferguson D.O. Multiple functions of MRN in end-joining pathways during isotype class switching. Nat. Struct. Mol. Biol. 2009, 16:808-813.
46. Di Noia J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 2007, 76:1-22.
47. Dorsett Y., Robbiani D.F., Jankovic M., Reina-San-Martin B., Eisenreich T.R., Nussenzweig M.C. A role for AID in chromosome translocations between c-myc and the IgH variable region. J. Exp. Med. 2007, 204:2225-2232.
48. Downs J.A., Lowndes N.F., Jackson S.P. A role for Saccharomyces cerevisiae histone H2A in DNA repair. Nature 2000, 408:1001-1004.
49. Druker B.J., Guilhot F., O'Brien S.G. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N. Engl. J. Med. 2006, 355:2408-2417.
50. Dudley D.D., Chaudhuri J., Bassing C.H., Alt F.W. Mechanism and control of V(D)J recombination versus class switch recombination: Similarities and differences. Adv. Immunol. 2005, 86:43-112.
51. Durkin S.G., Glover T.W. Chromosome fragile sites. Annu. Rev. Genet. 2007, 41:169-192.
52. Falck J., Coates J., Jackson S.P. Conserved modes of recruitment of ATM, ATR and DNA-PKCS to sites of DNA damage. Nature 2005, 434:605-611.
53. Felsher D.W. Tumor dormancy and oncogene addiction. APMIS 2008, 116:629-637.
54. Ferguson D.O., Alt F.W. DNA double strand break repair and chromosomal translocation: Lessons from animal models. Oncogene 2001, 20(40):5572-5579.
55. Ferguson D.O., Sekiguchi J.M., Chang S., Frank K.M., Gao Y., DePinho R.A., Alt F.W. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc. Natl. Acad. Sci. USA 2000, 97:6630-6633.
56. Foster H.A., Bridger J.M. The genome and the nucleus: A marriage made by evolution. Genome organisation and nuclear architecture. Chromosoma 2005, 114:212-229.
57. Franco S., Gostissa M., Zha S., Lombard D.B., Murphy M.M., Zarrin A.A., Yan C., Tepsuporn S., Morales J.C., Adams M.M., Lou Z., Bassing C.H., et al. H2AX prevents DNA breaks from progressing to chromosome breaks and translocations. Mol. Cell 2006, 21:201-214.
58. Franco S., Alt F.W., Manis J.P. Pathways that suppress programmed DNA breaks from progressing to chromosomal breaks and translocations. DNA Repair (Amst.) 2006, 5:1030-1041.
59. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 2000, 5:993-1002.
60. Fröhling S., Döhner H. Chromosomal abnormalities in cancer. N. Engl. J. Med. 2008, 359:722-734.
61. Futreal P.A., Coin L., Marshall M., Down T., Hubbard T., Wooster R., Rahman N., Stratton M.R. A census of human cancer genes. Nat. Rev. Cancer 2004, 4:177-183.
62. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., Bronson R.T., Malynn B.A., Bryans M., Zhu C., Chaudhuri J., Davidson L., Ferrini R., Stamato T., Orkin S.H., Greenberg M.E., Alt F.W. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 1998, 95:891-902.
63. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 2000, 404:897-900.
64. Gell D., Jackson S.P. Mapping of protein-protein interactions within the DNA-dependent protein kinase complex. Nucleic Acids Res. 1999, 27:3494-3502.
65. Gilfillan S., Dierich A., Lemeur M., Benoist C., Mathis D. Mice lacking TdT: Mature animals with an immature lymphocyte repertoire. Science 1993, 261:1175-1178.
66. Gillert E., Leis T., Repp R., Reichel M., Hösch A., Breitenlohner I., Angermüller S., Borkhardt A., Harbott J., Lampert F., Griesinger F., Greil J., et al. DNA damage repair mechanism is involved in the origin of chromosomal translocations. Oncogene 1999, 18:4663-4671.
67. Gladdy R.A., Taylor M.D., Williams C.J., Grandal I., Karaskova J., Squire J.A., Rutka J.T., Guidos C.J., Danska J.S. The RAG-1/2 endonuclease causes genomic instability and controls CNS complications of lymphoblastic leukemia in p53/Prkdc-deficient mice. Cancer Cell 2003, 3:37-50.
68. Goldman J.M., Melo J.V. Chronic myeloid leukemia-Advances in biology and new approaches to treatment. N. Engl. J. Med. 2003, 349:1451-1464.
69. Gostissa M., Yan C.T., Bianco J.M., Cogné M., Pinaud E., Alt F.W. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region. Nature 2009, 462:803-807.
70. Gostissa M., Ranganath S., Bianco J.M., Alt F.W. Chromosomal location targets different MYC family gene members for oncogenic translocations. Proc. Natl. Acad. Sci. USA 2009, 106:2265-2270.
71. Grawunder U., Wilm M., Wu X., Kulesza P., Wilson T.E., Mann M., Lieber M.R. Activity of DNA ligase IV stimulated by complex formation with XRCC4 protein in mammalian cells. Nature 1997, 388:492-495.
72. Groffen J., Stephenson J.R., Heisterkamp N., de Klein A., Bartram C.R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984, 36:93-99.
73. Guirouilh-Barbat J., Huck S., Bertrand P., Pirzio L., Desmaze C., Sabatier L., Lopez B.S. Impact of the KU80 pathway on NHEJ-induced genome rearrangements in mammalian cells. Mol. Cell 2004, 14:611-623.
74. Han L., Yu K. Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV-deficient B cells. J. Exp. Med. 2008, 205:2745-2753.
75. Harrington J., Hsieh C.L., Gerton J., Bosma G., Lieber M.R. Analysis of the defect in DNA end joining in the murine scid mutation. Mol. Cell Biol. 1992, 12:4758-4768.
76. Heisterkamp N., Stephenson J.R., Groffen J. Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 1983, 306:239-242.
77. Hesse J.E., Lieber M.R., Mizuuchi K., Gellert M. V(D)J recombination: A functional definition of the joining signals. Genes Dev. 1989, 3:1053-1061.
78. Hoeijmakers J.H. DNA damage, aging, and cancer. N. Engl. J. Med. 2009, 361:1475.
79. Hughes T., Deininger M., Hochhaus A., Branford S., Radich J., Kaeda J., Baccarani M., Cortes J., Cross N.C., Druker B.J., Gabert J., Grimwade D., et al. Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: Review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 2006, 108:28-37.
80. Huye L.E., Purugganan M.M., Jiang M.M., Roth D.B. Mutational analysis of all conserved basic amino acids in RAG-1 reveals catalytic, step arrest, and joining-deficient mutants in the V(D)J recombinase. Mol. Cell Biol. 2002, 22:3460-3473.
81. Iliakis G., Wang H., Perrault A.R., Boecker W., Rosidi B., Windhofer F., Wu W., Guan J., Terzoudi G., Pantelias G. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet. Genome Res. 2004, 104:14-20.
82. Ivanov E.L., Sugawara N., Fishman-Lobell J., Haber J.E. Genetic requirements for the single-strand annealing pathway of double-strand break repair in Saccharomyces cerevisiae. Genetics 1996, 142:693-704.
83. Janz S. Myc translocations in B cell and plasma cell neoplasms. DNA Repair 2006, 5:1213-1224.
84. Ji Y., Resch W., Corbett E., Yamane A., Casellas R., Schatz D.G. The in vivo pattern of binding of RAG1 and RAG2 to antigen receptor loci. Cell 2010, 141:419-431.
85. Kabotyanski E.B., Gomelsky L., Han J.O., Stamato T.D., Roth D.B. Double-strand break repair in Ku86- and XRCC4-deficient cells. Nucleic Acids Res. 1998, 26:5333-5342.
86. Kim D.R., Park S.J., Oettinger M.A. V(D)J recombination: Site-specific cleavage and repair. Mol. Cells 2000, 10:367-374.
87. Kinner A., Wu W., Staudt C., Iliakis G. γ-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res. 2008, 36:5678-5694.
88. Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K., Matsuura S., Kobayashi T., Tamai K., Tanimoto K., Komatsu K. NBS1 localizes to g-H2AX foci through interaction with the FHA/BRCT domain. Curr. Biol. 2002, 12:1846-1851.
89. Kohl N.E., Kanda N., Schreck R.R., Bruns G., Latt S.A., Gilbert F., Alt F.W. Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 1983, 35:359-367.
90. Komori T., Okada A., Stewart V., Alt F.W. Lack of N regions in antigen receptor variable region genes of TdT-deficient lymphocytes. Science 1993, 261:1171-1175.
91. Kreslavsky T., Gleimer M., von Boehmer H. Alphabeta versus gammadelta lineage choice at the first TCR-controlled checkpoint. Curr. Opin Immunol. 2010, 22:185-192.
92. Küppers R. Mechanisms of B-cell lymphoma pathogenesis. Nat. Rev. Cancer 2005, 5:251-262.
93. Küppers R., Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001, 20:5580-5594.
94. LanctÔt C., Cheutin T., Cremer M., Cavalli G., Cremer T. Dynamic genome architecture in the nuclear space: Regulation of gene expression in three dimensions. Nat. Rev. Genet. 2007, 8:104-115.
95. Lee S.E., Mitchell R.A., Cheng A., Hendrickson E.A. Evidence for DNA-PK-dependent and DNA-PK-independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol. Cell Biol. 1997, 17:1425-1433.
96. Lee G.S., Neiditch M.B., Salus S.S., Roth D.B. RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination. Cell 2004, 117:171-184.
97. Li X., Heyer W.D. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008, 18:99-113.
98. Li Z., Woo C.J., Iglesias-Ussel M.D., Ronai D., Scharff M.D. The generation of antibody diversity through somatic hypermutation and class switch recombination. Genes Dev. 2004, 18:1-11.
99. Li G., Alt F.W., Cheng H.L., Brush J.W., Goff P.H., Murphy M.M., Franco S., Zhang Y., Zha S. Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Mol. Cell 2008, 31:631-640.
100. Liang F., Han M., Romanienko P.J., Jasin M. Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc. Natl. Acad. Sci. USA 1998, 95:5172-5177.
101. Lieber M.R., Ma Y., Pannicke U., Schwarz K. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair (Amst.) 2004, 3:817-826.
102. Lieberman-Aiden E., van Berkum N.L., Williams L., Imakaev M., Ragoczy T., Telling A., Amit I., Lajoie B.R., Sabo P.J., Dorschner M.O., Sandstrom R., Bernstein B., et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293.
103. Lin F.L., Sperle K., Sternberg N. Model for homologous recombination during transfer of DNA into mouse L cells: Role for DNA ends in the recombination process. Mol. Cell. Biol. 1984, 4:1020-1034.
104. Lin Y., Lukacsovich T., Waldman A.S. Multiple pathways for repair of double-strand breaks in mammalian chromosomes. Mol. Cell. Biol. 1999, 19:8353-8360.
105. Lin C., Yang L., Tanasa B., Hutt K., Ju B.G., Ohgi K., Zhang J., Rose D.W., Fu X.D., Glass C.K., Rosenfeld M.G. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009, 139:1069-1083.
106. Lisby M., Mortensen U.H., Rothstein R. Colocalization of multiple DNA double-strand breaks at a single Rad52 repair centre. Nat. Cell Biol. 2003, 5:572-577.
107. Liu Y., Subrahmanyam R., Chakraborty T., Sen R., Desiderio S. A plant homeodomain in RAG-2 that binds hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity 2007, 27:561-571.
108. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., Schatz D.G. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
109. Mahajan K.N., Nick McElhinny S.A., Mitchell B.S., Ramsden D.A. Association of DNA polymerase mu (pol mu) with Ku and ligase IV: Role for pol mu in end-joining double-strand break repair. Mol. Cell. Biol. 2002, 22:5194-5202.
110. Mahowald G.K., Baron J.M., Mahowald M.A., Kulkarni S., Bredemeyer A.L., Bassing C.H., Sleckman B.P. Aberrantly resolved RAG-mediated DNA breaks in Atm-deficient lymphocytes target chromosomal breakpoints in cis. Proc. Natl. Acad. Sci. USA 2009, 106:18339-18344.
111. Malynn B.A., de Alboran I.M., O'Hagan R.C., Bronson R., Davidson L., DePinho R.A., Alt F.W. N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev. 2000, 14:1390-1399.
112. Mani R.S., Tomlins S.A., Callahan K., Ghosh A., Nyati M.K., Varambally S., Palanisamy N., Chinnaiyan A.M. Science 2009, 326:1230.
113. Mari P.O., Florea B.I., Persengiev S.P., et al. Dynamic assembly of end-joining complexes requires interaction between Ku70/80 and XRCC4. Proc. Natl. Acad. Sci. USA 2006, 103:18597-18602.
114. Martelli M.P., Sozzi G., Hernandez L., Pettirossi V., Navarro A., Conte D., Gasparini P., Perrone F., Modena P., Pastorino U., Carbone A., Fabbri A., et al. EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues. Am. J. Pathol. 2009, 174:661-670.
115. Martín-Subero I., Odero M.D., Hernandez R., Cigudosa J.C., Agirre X., Saez B., Sanz-García E., Ardanaz M.T., Novo F.J., Gascoyne R.D., Calasanz M.J., Siebert R. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas. Genes Chromosomes Cancer 2005, 43:414-423.
116. Matsumoto Y., Marusawa H., Kinoshita K., Endo Y., Kou T., Morisawa T., Azuma T., Okazaki I.M., Honjo T., Chiba T. Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium. Nat. Med. 2007, 13:470-476.
117. Matthews A.G., Kuo A.J., Ramón-Maiques S., Han S., Champagne K.S., Ivanov D., Gallardo M., Carney D., Cheung P., Ciccone D.N., Walter K.L., Utz P.J., et al. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature 2007, 450:1106-1110.
118. Max E.E., Seidman J.G., Leder P. Sequences of five potential recombination sites encoded close to an immunoglobulin kappa constant region gene. Proc. Natl. Acad. Sci. USA 1979, 76:3450-3454.
119. McDonnell T.J., Korsmeyer S.J. Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991, 349:254-256.
120. McDonnell T.J., Deane N., Platt F.M., Nunez G., Jaeger U., McKearn J.P., Korsmeyer S.J. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989, 57:79-88.
121. Meaburn K.J., Misteli T., Soutoglou E. Spatial genome organization in the formation of chromosomal translocations. Semin. Cancer Biol. 2007, 17:80-90.
122. Mickelsen S., Snyder C., Trujillo K., Bogue M., Roth D.B., Meek K. Modulation of terminal deoxynucleotidyltransferase activity by the DNA-dependent protein kinase. J. Immunol. 1999, 163:834-843.
123. Mills K.D., Ferguson D.O., Alt F.W. The role of DNA breaks in genomic instability and tumorigenesis. Immunol. Rev. 2003, 194:77-95.
124. Mills K.D., Ferguson D.O., Essers J., Eckersdorff M., Kanaar R., Alt F.W. Rad54 and DNA Ligase 4 cooperate to maintain mammalian chromatid stability. Genes Dev. 2004, 18:1283-1292.
125. Mitelman F., Johansson B., Mertens F. The impact of translocations and gene fusions on cancer causation. Nat. Rev. Cancer 2007, 7:233-245.
126. Mombaerts P., Iacomini J., Johnson R.S., Herrup K., Tonegawa S., Papaioannou V.E. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992, 68:869-877.
127. Monroe R.J., Seidl K.J., Gaertner F., Han S., Chen F., Sekiguchi J., Wang J., Ferrini R., Davidson L., Kelsoe G., Alt F.W. RAG2:GFP knockin mice reveal novel aspects of RAG2 expression in primary and peripheral lymphoid tissues. Immunity 1999, 11:201-212.
128. Morgenbesser S.D., DePinho R.A. Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer. Semin. Cancer Biol. 1994, 5:21-36.
129. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., de Villartay J.P. Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell 2001, 105:177-186.
130. Mundy C.L., Patenge N., Matthews A.G., Oettinger M.A. Assembly of the RAG1/RAG2 synaptic complex. Mol. Cell Biol. 2002, 22:69-77.
131. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
132. Muramatsu M., Nagaoka H., Shinkura R., Begum N.A., Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv. Immunol. 2007, 94:1-36.
133. Niewolik D., Pannicke U., Lu H., et al. DNA-PKCS dependence of Artemis endonucleolytic activity, differences between hairpins and 5' or 3' overhangs. J. Biol. Chem. 2006, 28:33900-33909.
134. Nikiforov Y.E. Thyroid carcinoma: Molecular pathways and therapeutic targets. Mod. Pathol. 2008, 21:37-43.
135. Nowell P.C., Hungerford D.A. Chromosome studies on normal and leukemic human leukocytes. J. Natl. Cancer Inst. 1960, 25:85-109.
136. Odegard V.H., Schatz D.G. Targeting of somatic hypermutation. Nat. Rev. Immunol. 2006, 6:573-583.
137. Oettinger M.A., Schatz D.G., Gorka C., Baltimore D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 1990, 248:1517-1523.
138. Okazaki I.M., Kotani A., Honjo T. Role of AID in tumorigenesis. Adv. Immunol. 2007, 94:245-273.
139. Parada L., Misteli T. Chromosome positioning in the interphase nucleus. Trends Cell Biol. 2002, 12(9):425-432.
140. Parada L., Sotiriou S., Misteli T. Spatial genome organization. Exp. Cell Res. 2004, 269:64-70.
141. Pasqualucci L., Bhagat G., Jankovic M., Compagno M., Smith P., Muramatsu M., Honjo T., Morse H.C., Nussenzweig M.C., Dalla-Favera R. AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 2008, 40:108-112.
142. Pear W.S., Miller J.P., Xu L., Pui J.C., Soffer B., Quackenbush R.C., Pendergast A.M., Bronson R., Aster J.C., Scott M.L., Baltimore D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 1998, 92:3780-3792.
143. Qiu J.X., Kale S.B., Yarnell S.H., Roth D.B. Separation-of-function mutants reveal critical roles for RAG2 in both the cleavage and joining steps of V(D)J recombination. Mol. Cell 2001, 7:77-87.
144. Ramiro A.R., Jankovic M., Eisenreich T., Difilippantonio S., Chen-Kiang S., Muramatsu M., Honjo T., Nussenzweig A., Nussenzweig M.C. AID is required for c-myc/IgH chromosome translocations in vivo. Cell 2004, 118:431-438.
145. Ramiro A.R., Jankovic M., Callen E., Difilippantonio S., Chen H.T., McBride K.M., Eisenreich T.R., Chen J., Dickins R.A., Lowe S.W., Nussenzweig A., Nussenzweig M.C. Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 2006, 440:105-109.
146. Ramón-Maiques S., Kuo A.J., Carney D., Matthews A.G., Oettinger M.A., Gozani O., Yang W. The plant homeodomain finger of RAG2 recognizes histone H3 methylated at both lysine-4 and arginine-2. Proc. Natl. Acad. Sci. USA 2007, 104:18993-18998.
147. Rass E., Grabarz A., Plo I., Gautier J., Bertrand P., Lopez B.S. Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells. Nat. Struct. Mol. Biol. 2009, 16:819-824.
148. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
149. Robbiani D.F., Bothmer A., Callen E., Reina-San-Martin B., Dorsett Y., Difilippantonio S., Bolland D.J., Chen H.T., Corcoran A.E., Nussenzweig A., Nussenzweig M.C. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 2008, 135:1028-1038.
150. Robbiani D.F., Bunting S., Feldhahn N., Bothmer A., Camps J., Deroubaix S., McBride K.M., Klein I.A., Stone G., Eisenreich T.R., Ried T., Nussenzweig A., et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 2009, 36:631-641.
151. Roberts S.A., Strande N., Burkhalter M.D., Strom C., Havener J.M., Hasty P., Ramsden D.A. Ku is a 5'-dRP/AP lyase that excises nucleotide damage near broken ends. Nature 2010, 464:1214-1217.
152. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
153. Rogakou E.P., Boon C., Redon C., Bonner W.M. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 1999, 146:905-916.
154. Rogozin I.B., Kolchanov N.A. Somatic hypermutagenesis in immunoglobulin genes. II. Influence of neighbouring base sequences on mutagenesis. Biochim. Biophys. Acta 1992, 1171:11-18.
155. Rooney S., Sekiguchi J., Whitlow S., Eckersdorff M., Manis J.P., Lee C., Ferguson D.O., Alt F.W. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc. Natl. Acad. Sci. USA 2004, 101:2410-2415.
156. Rooney S., Chaudhuri J., Alt F.W. The role of the non-homologous end-joining pathway in lymphocyte development. Immunol. Rev. 2004, 200:115-131.
157. Rowley J.D. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973, 243:290.
158. Sakano H., Hüppi K., Heinrich G., Tonegawa S. Sequences at the somatic recombination sites of immunoglobulin light-chain genes. Nature 1979, 280:288-294.
159. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
160. Savic V., Yin B., Maas N.L., Bredemeyer A.L., Carpenter A.C., Helmink B.A., Yang-Iott K.S., Sleckman B.P., Bassing C.H. Formation of dynamic gamma-H2AX domains along broken DNA strands is distinctly regulated by ATM and MDC1 and dependent upon H2AX densities in chromatin. Mol. Cell 2009, 34:298-310.
161. Schatz D.G., Baltimore D. Stable expression of immunoglobulin gene V(D)J recombinase activity by gene transfer into 3T3 fibroblasts. Cell 1988, 53:107-115.
162. Schatz D.G., Oettinger M.A., Baltimore D. The V(D)J recombination activating gene, RAG-1. Cell 1989, 59:1035-1048.
163. Schmidt E.V., Pattengale P.K., Weir L., Leder P. Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: A pre-B-cell lymphoma model. Proc. Natl. Acad. Sci. USA 1988, 85:6047-6051.
164. Schüler F., Hirt C., Dölken G. Chromosomal translocation t(14;18) in healthy individuals. Semin. Cancer Biol. 2003, 13:203-209.
165. Sekiguchi J.A., Whitlow S., Alt F.W. Increased accumulation of hybrid V(D)J joins in cells expressing truncated versus full-length RAGs. Mol. Cell 2001, 8:1383-1390.
166. Shimazaki N., Tsai A.G., Lieber M.R. H3K4me3 stimulates the V(D)J RAG complex for both nicking and hairpinning in trans in addition to tethering in cis: Implications for translocations. Mol. Cell 2009, 34:535-544.
167. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M., Alt F.W. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992, 68:855-867.
168. Simsek D., Jasin M. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat. Struct. Mol. Biol. 2010, 17:410-416.
169. Singleton B.K., Torres-Arzayus M.I., Rottinghaus S.T., Taccioli G.E., Jeggo P.A. The C terminus of Ku80 activates the DNA-dependent protein kinase catalytic subunit. Mol. Cell. Biol. 1999, 19:3267-3277.
170. Soda M., Choi Y.L., Enomoto M., Takada S., Yamashita Y., Ishikawa S., Fujiwara S., Watanabe H., Kurashina K., Hatanaka H., Bando M., Ohno S., et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007, 448:561-566.
171. Soda M., Takada S., Takeuchi K., Choi Y.L., Enomoto M., Ueno T., Haruta H., Hamada T., Yamashita Y., Ishikawa Y., Sugiyama Y., Mano H. A mouse model for EML4-ALK-positive lung cancer. Proc. Natl. Acad. Sci. USA 2008, 105:19893-19897.
172. Soutoglou E., Dorn J.F., Sengupta K., Jasin M., Nussenzweig A., Ried T., Danuser G., Misteli T. Positional stability of single double-strand breaks in mammalian cells. Nat. Cell Biol. 2007, 9:675-682.
173. Spagnolo L., Rivera-Calzada A., Pearl L.H., Llorca O. Three-dimensional structure of the human DNA-PKCS/Ku70/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol. Cell 2006, 22:511-519.
174. Stavnezer J., Guikema J.E., Schrader C.E. Mechanism and regulation of class switch recombination. Annu. Rev. Immunol. 2008, 26:261-292.
175. Stephens P.J., McBride D.J., Lin M.L., Varela I., Pleasance E.D., Simpson J.T., Stebbings L.A., Leroy C., Edkins S., Mudie L.J., Greenman C.D., Jia M., et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009, 462:1005-1010.
176. Stewart G.S., Wang B., Bignell C.R., Taylor A.M., Elledge S.J. MDC1 is a mediator of the mammalian DNA damage checkpoint. Nature 2003, 421:961-966.
177. Strathern J.N., Shafer B.K., McGill C.B. DNA synthesis errors associated with double-strand-break repair. Genetics 1995, 140:965-972.
178. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458:719-724.
179. Taccioli G.E., Rathbun G., Oltz E., Stamato T., Jeggo P.A., Alt F.W. Impairment of V(D)J recombination in double-strand break repair mutants. Science 1993, 260:207-210.
180. Takata M., Sasaki M.S., Sonoda E., et al. Homologous recombination and non-homologous end-joining pathways of DNA doublestrand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 1998, 17:5497-5508.
181. Tonegawa S. Somatic generation of antibody diversity. Nature 1983, 302:575-581.
182. Truffinet V., Pinaud E., Cogné N., Petit B., Guglielmi L., Cogné M., Denizot Y. The 3' IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J. Immunol. 2007, 179:6033-6042.
183. Tsai A.G., Lu H., Raghavan S.C., Muschen M., Hsieh C.L., Lieber M.R. Human chromosomal translocations at CpG sites and a theoretical basis for their lineage and stage specificity. Cell 2008, 135:1130-1142.
184. Uchiyama Y., Takeuchi R., Kodera H., Sakaguchi K. Distribution and roles of X-family DNA polymerases in eukaryotes. Biochimie 2009, 91:165-170.
185. van den Bosch M., Bree R.T., Lowndes N.F. The MRN complex: Coordinating and mediating the response to broken chromosomes. EMBO Rep. 2003, 4:844-849.
186. Verkaik N.S., Esveldt-van Lange R.E., van Heemst D., Brüggenwirth H.T., Hoeijmakers J.H., Zdzienicka M.Z., van Gent D.C. Different types of V(D)J recombination and end-joining defects in DNA double-strand break repair mutant mammalian cells. Eur. J. Immunol. 2002, 32:701-709.
187. Villa A., Santagata S., Bozzi F., Imberti L., Notarangelo L.D. Omenn syndrome: A disorder of Rag1 and Rag2 genes. J. Clin. Immunol. 1999, 19:87-97.
188. Vogelstein B., Lane D., Levine A.J. Surfing the p53 network. Nature 2000, 408:307-310.
189. Wagner S.D., Milstein C., Neuberger M.S. Codon bias targets mutation. Nature 1995, 376:732.
190. Walker J.R., Corpina R.A., Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 2001, 412:607-614.
191. Wang H., Perrault A.R., Takeda Y., Qin W., Wang H., Iliakis G. Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res. 2003, 31:5377-5388.
192. Wang H., Rosidi B., Perrault R., Wang M., Zhang L., Windhofer F., Iliakis G. DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res. 2005, 65:4020-4030.
193. Wang M., Wu W., Wu W., Rosidi B., Zhang L., Wang H., Iliakis G. PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways. Nucleic Acids Res. 2006, 34:6170-6182.
194. Wang J.H., Alt F.W., Gostissa M., Datta A., Murphy M., Alimzhanov M.B., Coakley K.M., Rajewsky K., Manis J.P., Yan C.T. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching. J. Exp. Med. 2008, 205:3079-3090.
195. Wang J.H., Gostissa M., Yan C.T., Goff P., Hickernell T., Hansen E., Difilippantonio S., Wesemann D.R., Zarrin A.A., Rajewsky K., Nussenzweig A., Alt F.W. Mechanisms promoting translocations in editing and switching peripheral B cells. Nature 2009, 460:231-236.
196. Ward I.M., Minn K., Jorda K.G., Chen J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J. Biol. Chem. 2003, 278:19579-19582.
197. Weinstock D.M., Richardson C.A., Elliott B., Jasin M. Modeling oncogenic translocations: Distinct roles of double strand break repair pathways in translocation formation in mammalian cells. DNA Repair 2006, 5:1065-1074.
198. Weinstock D.M., Elliott B., Jasin M. A model of oncogenic rearrangements: Differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 2006, 107:777-780.
199. Weinstock D.M., Brunet E., Jasin M. Induction of chromosomal translocations in mouse and human cells using site-specific endonucleases. J. Natl. Cancer Inst. Monogr. 2008, 39:20-24.
200. Xie A., Kwok A., Scully R. Role of mammalian Mre11 in classical and alternative nonhomologous end joining. Nat. Struct. Mol. Biol. 2009, 16:814-818.
201. Yan C.T., Kaushal D., Murphy M., Zhang Y., Datta A., Chen C., Monroe B., Mostoslavsky G., Coakley K., Gao Y., Mills K.D., Fazeli A.P., et al. XRCC4 suppresses medulloblastomas with recurrent translocations in p53-deficient mice. Proc. Natl. Acad. Sci. USA 2006, 103:7378-7383.
202. Yan C.T., Boboila C., Souza E.K., Franco S., Hickernell T.R., Murphy M., Gumaste S., Geyer M., Zarrin A.A., Manis J.P., Rajewsky K., Alt F.W. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007, 449:478-482.
203. Yaneva M., Kowalewski T., Lieber M.R. Interaction of DNA-dependent protein kinase with DNA and with Ku: Biochemical and atomic-force microscopy studies. EMBO J. 1997, 16:5098-5112.
204. Yannoutsos N., Wilson P., Yu W., Chen H.T., Nussenzweig A., Petrie H., Nussenzweig M.C. The role of recombination activating gene (RAG) reinduction in thymocyte development in vivo. J. Exp. Med. 2001, 194:471-480.
205. Yarnell S.H., Landree M.A., Qiu J.X., Kale S.B., Roth D.B. Joining-deficient RAG1 mutants block V(D)J recombination in vivo and hairpin opening in vitro. Mol. Cell 2001, 7:65-75.
206. Youle R.J., Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
207. Yu W., Nagaoka H., Misulovin Z., Meffre E., Suh H., Jankovic M., Yannoutsos N., Casellas R., Besmer E., Papavasiliou F., Qin X., Nussenzweig M.C. RAG expression in B cells in secondary lymphoid tissues. Cold Spring Harb. Symp. Quant. Biol. 1999, 64:207-210.
208. Zarrin A.A., Del Vecchio C., Tseng E., Gleason M., Zarin P., Tian M., Alt F.W. Antibody class switching mediated by yeast endonuclease-generated DNA breaks. Science 2007, 315:377-381.
209. Zha S., Boboila C., Alt F.W. Mre11: Roles in DNA repair beyond homologous recombination. Nat. Struct. Mol. Biol. 2009, 16:798-800.
210. Zha S., Bassing C.H., Sanda T., Brush J.W., Patel H., Goff P.H., Murphy M.M., Tepsuporn S., Gatti R.A., Look A.T., Alt F.W. ATM-deficient thymic lymphoma is associated with aberrant Tcrδ rearrangement and gene amplification. J. Exp. Med. 2010, 207:1369-1380.
211. Zhang X., Ren R. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998, 92:3829-3840.
212. Zhang Y., Rowley J.D. Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair 2006, 5:1282-1297.
213. Zhang F., Carvalho C.M., Lupski J.R. Complex human chromosomal and genomic rearrangements. Trends Genet. 2009, 25:298-307.
214. Zhang T., Franklin A., Boboila C., McQuay A., Gallagher M.P., Manis J.P., Khamlichi A.A., Alt F.W. Downstream class switching leads to IgE antibody production by B lymphocytes lacking IgM switch regions. Proc. Natl. Acad. Sci. USA 2010, 107:3040-3045.
215. Zhao J., Bacolla A., Wang G., Vasquez K.M. Non-B DNA structure-induced genetic instability and evolution. Cell Mol. Life Sci. 2010, 67:43-62.
216. Zhu C., Mills K.D., Ferguson D.O., Lee C., Manis J., Fleming J., Gao Y., Morton C.C., Alt F.W. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002, 109:811-821.
217. Zimmerman K.A., Yancopoulos G.D., Collum R.G., Smith R.K., Kohl N.E., Denis K.A., Nau M.M., Witte O.N., Toran-Allerand D., Gee C.E., Minna J.D., Alt F.W. Differential expression of myc family genes during murine development. Nature 1986, 319:780-783.
218. Zitzelsberger H., Bauer V., Thomas G., Unger K. Molecular rearrangements in papillary thyroid carcinomas. Clin. Chim. Acta 2010, 411:301-308.